Efficacy of melatonin on sleep quality After spine surgery

Efficacy of melatonin on sleep quality After spine surgery Using the Pittsburgh Sleep Quality Index (PSQI)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250526065913N1

Enrollment

Registered

2025-08-23

Start date

2025-09-23

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep quality.

Interventions

Intervention 1: “Patients in the intervention group will receive 42 oral tablets, taking one 6 mg melatonin tablet (brand name: SleepMed) orally each night at bedtime for 6 weeks. The melatonin tablet

Eligibility

Sex/Gender

All

Age

No minimum to 80 Years

Inclusion criteria

Inclusion criteria: Patients Who Have Undergone Spinal Surgery and Are Able to Complete the Study

Exclusion criteria

Exclusion criteria: Patients Who Are Taking Melatonin or Other Sleep Medications, Antidepressants, Antipsychotic Drugs, Opioid Medications, and Warfarin History of Insomnia History of Obstructive Sleep Apnea Inflammatory Conditions Age Over 80

Design outcomes

Primary

Measure	Time frame
Sleep quality according to the PSQI questionnaire. Timepoint: At three time points: pre-surgery, 2 weeks post-surgery, and 6 weeks post-surgery. Method of measurement: PSQI questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParham Talebian

Tehran University of Medical Sciences

ptalebian@sina.tums.ac.ir+98 21 6312 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026